Consistent with those experimental studies, serum CTRP9 levels were found to be inversely related to obesity, insulin resistance, and dyslipidemia in a community-based population [15] and in patients with coronary artery disease [16]. Here, C1QTNF9 is linked to obesity due to melanocortin 4 receptor deficiency.